Medical Equipment Wholesale Company Seeking Loan in Tehran, Iran

We purchase pharmaceuticals, medical equipment, industrial flavoring agents in Iran and export to buyers in other countries.
Flavoring agents are used by domestic companies and factories. Tangible assets.
1. Strategic container depots in multiple major cities in Iran.
2. Advanced machinery and equipment for container storage and logistics operations.
3. Vehicles for transport and logistics (trucks, forklifts, etc. )
4. Warehouse equipment (racks, pallets, forklifts, climate-control systems for pharmaceuticals)
5. Office facilities (owned and leased)
6. Inventory of pharmaceuticals, medical equipment, and flavoring agents.
Intangible assets.
1. Brand reputation and goodwill.
2. Licenses, certifications, and approvals for pharmaceuticals, medical equipment, and logistics operations.
3. International trade relationships and contracts with foreign partners.
4. Customer base (existing and potential clients)
5. Proprietary logistics and supply chain management processes. Operates strategic container depots in several major cities across Iran, equipped with advanced machinery and equipment for container storage and management. All sites feature high security and a combination of owned and long-term leased properties and warehouses, ensuring operational stability and flexibility for domestic and international clients. The group enjoys strong domestic and international credibility and maintains multiple agencies and partnerships with international companies. Funded entirely through founder equity.
The main founder and owner contributed USD 500,000. The company does not have any external or strategic investors; however, it has received USD 1,000,000 worth of goods on credit from foreign companies. The registered capital of the company is 1 billion IRR, with an additional in-kind capital of USD 1,000,000. The company has no outstanding debts or loans, ensuring a strong financial position.
Ownership is held by three shareholders: the founding promoter holds 85%, while other internal partners hold 5% and 10%, respectively, with no external investors. This 100% founder-funded structure provides financial stability, operational flexibility, and the ability to launch new projects. It also enables rapid response to domestic and international business opportunities, minimizing financial risk.